Head’s Office

 Department Head: Dr. Lakshmi Yahtam

 

Dr. Yatham, Professor in the Department of Psychiatry, is also the Regional Head of Psychiatry and Regional Program Medical Director for Mental Health and Addictions at Vancouver Coastal Health and Providence Health Care. He has held leadership positions for national and international professional organizations including President of the International Society for Bipolar Disorders, Secretary for the World Federation of Societies of Biological Psychiatry (SFSBP), and is now the President-Elect for the SFSBP. Dr. Yatham’s major areas of research interest include neurobiology and treatment of bipolar disorder and major depression.

 

Associate Head – Clinical Affairs: William MacEwan

Bill_MacEwan-300x244

Dr. William MacEwan received his BSc, MD and FRCPC (1987) from the University of BC. He is an outstanding teacher and clinician who practices psychiatry in two community settings – Vancouver’s Downtown Eastside and the South Fraser Health Region. His research interests have been in the study of novel antipsychotics in the treatment of schizophrenia. He is a rare clinical teacher who can impact on the care of communities through his dedication and passion for teaching as demonstrated by his being awarded in 2012 the Faculty of Medicine’s Clinical Faculty Award for Excellence in Community Practice Teaching.   He is a dedicated advocate for people with serious mental illness living in poverty on Vancouver’s Downtown Eastside and currently sits on the Mayor’s Mental Health and Addictions Task Force

 

Associate Head – Research: Raymond Lam

Lam-Raymond_croppedDr. Raymond W. Lam is Professor and Head of the Mood and Anxiety Disorders Program in the Department of Psychiatry, University of British Columbia, and Director of the Mood Disorders Centre of Excellence at UBC Hospital within the Vancouver Coastal Health Research Institute. His research covers the spectrum of non-pharmacologic and pharmacologic treatments for mood disorders, with a focus on seasonal, treatment-resistant and workplace depression. He has published over 230 papers in peer-reviewed journals and authored 11 books on depression, and serves on the editorial boards of 7 international journals, including as an editorial advisor for the Cochrane Collaboration. He is also the Executive Chair of the Canadian Network for Mood and Anxiety Treatments (CANMAT, www.canmat.org)